All News

Neil Gross, MD, FACS, MD Anderson Cancer Center

Patients may be able to forgo radiation following use of cemiplimab to treat their resectable cutaneous squamous cell carcinoma (cSCC), as it is likely to demonstrate significant improvement in quality of life (QOL) for patients and enable less invasive surgeries, noted Neil D. Gross, MD, FACS, head and neck surgeon and director of clinical research in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center.

Emily Brigham, MD

Urban areas face a concentration of various pollutants that will be exacerbated by the increasing temperatures caused by climate change, and low-income residents likely have fewer resources to withstand negative health impacts, according to Emily Brigham, MD, MHS, of the University of British Columbia.

Amresh Raina, MD, Allegheny Health Network

There is potential impact on the heart, coronary arteries, and heart function following radiation to the left side of the body, explained Amresh Raina, MD, director of the Advanced Heart Failure and Pulmonary Hypertension Program at Allegheny General Hospital and the Allegheny Health Network in Pittsburgh, Pennsylvania.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo